Vamsi Labs is an API manufacturer based in India. It holds 14 active US drug master files and 12 valid CEPs across a filed portfolio of 15 molecules. Its GMP standing is certified by EMA. Its most recent recorded inspection, by US FDA, closed on 16 March 2018 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Solapur, India | 3004644745 |
| Molecule | Regulators | Docs |
|---|---|---|
| Albuterol | EDQM, US FDA | 3 |
| Fluticasone Propionate | EDQM, US FDA | 3 |
| Formoterol | EDQM, US FDA | 3 |
| Haloperidol | EDQM, US FDA | 3 |
| Tiotropium | SFDA (Saudi Arabia), US FDA | 3 |
| Ipratropium | EDQM, SFDA (Saudi Arabia) | 2 |
| Loperamide | US FDA | 2 |
| Triamcinolone | US FDA | 2 |
| Budesonide | EDQM | 1 |
| Clenbuterol | EDQM | 1 |
| Fenoterol | EDQM | 1 |
| Fluticasone Furoate | EDQM | 1 |
| Glycopyrronium | EDQM | 1 |
| Salmeterol Xinafoate | EDQM | 1 |
| Tiotropium Bromide Monohydrate | EDQM | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| EMA | None | 1 |
Choose your molecules and target markets. Vamsi Labs comes back tiered against every other supplier able to file there.
Start for free